Androgen Use by Athletes: A Re evaluation of the Health Risks

Canadian Journal of Applied Physiology

Volumn 21, Issue 6, 1996, Pages 421-440

  Street, Chris ^a   Antonio, Jose ^b   Cudlipp, David ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b TEXAS WOMAN'S UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Exercise; Hypertrophy; Muscle; Steroids; Testosterone

Indexed keywords

ANABOLIC AGENT; ANDROGEN;

DOPING; FEMALE; HEALTH; HUMAN; MALE; REVIEW; SPORT; SPORTS MEDICINE;

ANABOLIC AGENTS; ANDROGENS; DOPING IN SPORTS; FEMALE; HEALTH; HUMANS; MALE; SPORTS; SPORTS MEDICINE;

EID: 0030344733     PISSN: 10667814     EISSN: None     Source Type: Journal    
DOI: 10.1139/h96-038     Document Type: Article

References (82)

1. Alen, M., and Rahkila, P. (1984). Reduced high-density lipoprotein-cholesterol in power athletes: Use of male sex hormone derivatives, an atherogenic factor. Int. J. Sports Med. 5(6): 341-342.
2. Alen, M., and Souminen, J. (1994). Effect of androgenic and anabolic steroids on spermatogenesis in power athletes. Int. J. Sports Med. 5(Suppl.): 189.
3. Annitto, W.J., and Layman, W.A. (1980). Anabolic steroids and acute schizophrenic episode. J. Clin. Psych. 41:4.
4. Appleby, M., Fisher, M., and Martin, M. (1994). Myocardial infarction, hyperkalemia and ventricular tachycardia in a young male bodybuilder. Int. J. Cardiol. 44: 171-174.
5. Bach, R.B., Warren, R.F., and Wickiewicz, T.L. (1987). Triceps rupture: A case report and literature review. Am. J. Sports. Med. 15: 285-289.
6. Bahrke, M.S., Wright, J.E., Strauss, R.H., and Catlin, D.H. (1992). Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use. Am. J. Sports Med. 20: 717-723.
7. Buckley, W.E., Yesalis, C.E., Friedl, K.E., Anderson, W.A., Streit, A.L., and Wright, J.E. (1988). Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 260: 3441-3445.
8. Cabasso, A. (1994). Peliosis hepatis in a young adult bodybuilder. Med. Sci. Sports Exerc. 26: 2-4.
9. Calabrese, L.H., Kleiner, S.M., Barna, B.P., Skibinski, C.I., Kirkendall, D.T., Lahita, R.G., and Lombardo, J.A. (1989). The effects of anabolic steroids and strength training on the human immune response. Med. Sci. Sports Exerc. 21: 386-392.
10. Cohen, J.C., and Hickman, R. (1987). Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J. Clin. Endo. Metab. 64: 960-963.
11. Cowart, V. (1987). Steroids in sports: After four decades time to return these genies to bottle. JAMA 257: 421.
12. Creagh, T.M., Rubin, A., and Evans, D.J. (1988). Hepatic tumors induced by anabolic steroids in an athlete. J. Clin. Path. 41: 441-443.
13. David, H.G., Green, J.T., Grant, A.J., and Wilson, C.A. (1994). Simultaneous bilateral quadriceps rupture: A complication of anabolic steroid abuse. J. Bone Joint Surg. Br. 77-B(1): 159-160.
14. Dessig, R., and Weissel, M. (1993). Ingestion of androgenic-anabolic steroids induces mild thyroidal impairment in male body builders. J. Clin. Endo. Metab. 76: 1069-1071.
15. Dickerman, R.D., Schaller, F., Prather, I., and McConathy, W.J. (1995). Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86: 172-173.
16. Ehrenkranz, J., Bliss, E., and Sheard, M.H. (1974). Plasma testosterone: Correlation with aggressive behavior and social dominance in man. Psychosom. Med. 36: 469-474.
17. Ferenchick, G.S. (1991). Anabolic-androgenic steroid abuse and thrombosis: Is there a connection? Med. Hypotheses. 35: 27-31.
18. Ferenchick, G.S., and Adelman, S. (1992). Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am. Heart J. 124(2): 507-508.
19. Frankle, M.A., Cicero, G.J., and Payne, J. (1984). Use of androgenic anabolic steroids by athletes. JAMA 252: 482.
20. Frankle, M.A., Eichberg, R., and Zachariah, S.B. (1988). Anabolic androgenic steroids and a stroke in an athlete: Case report. Arch. Phy. Med. Rehab. 69: 632-634.
21. Freeman, B.J.C., and Rooker, G.D.(1995). Spontaneous rupture of the anterior cruciate ligament after anabolic steroids. Br. J. Sports Med. 29: 274-275.
22. Friedl, K.E. (1990). Reappraisal of the health risks associated with the use of high doses of oral and injectable androgenic steroids. NIDA Res. Monogr. 102: 142-177.
23. Friedl, K.E., Hannan, C.J., Jones, R.E., and Plymate, S.R. (1990). High density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Metabolism 39: 69-74.
24. Freinhar J.P., and Alvarez, W. (1985). Androgen-induced hypomania. J. Clin. Psych. 46: 354-355.
25. Goldstein, P. (1990). Anabolic steroids: An ethnographic approach. NIDA Res. Monogr. 102: 74-96.
26. Goldman, B. (1985). Liver carcinoma in an athlete taking anabolic steroids. J. Am. Osteopath. Assoc. 85: 56.
27. Haupt, H.A., and Rovere, G.D. (1984). Anabolic steroids: A review of the literature. Am. J. Sports Med. 12: 469-484.
28. Herrick, R.T., and Herrick, S. (1987). Ruptured triceps in a powerlifter presenting as cubital syndrome: A case report. Am. J. Sports. Med. 15: 514-516.
29. Hill, J.A., Suker, J.R., Sachs, K., and Brigham, C. (1983). The athletic polydrug abuse phenomenon. Am. J. Sports Med. 11: 269-271.
30. Hobbs, C.J., Jones, R.E., and Plymate, S.R. (1996). Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men. J. Clin. Endocrinol. Metabol. 81: 1582-1585.
31. Holma, P.K. (1977). Effects of an anabolic steroid (metandienone) on spermatogenesis. Contraception 15: 155-162.
32. Huie, M.J. (1994). An acute myocardial infarction occurring in an anabolic steroid user. Med. Sci. Sports Exerc. 26: 408-413.
33. Hurley, B.F., Seals, D.R., Hagberg, J.M., Goldberg, A.C., Ostrove, S.M., Holloszy, J.O., Wiest, W.G., and Goldberg, A.P. (1984). High-density-lipoprotein cholesterol in bodybuilders vs. powerlifters: Negative effects of androgen use. JAMA. 252: 507-513.
34. Jaillard, A.S., Hommel, M., and Mallaret, M. (1994). Venous sinus thrombosis associated with androgens in a healthy young man. Stroke 25: 212-213.
35. Kantor, M.A., Bianchini, A., Bernier, D., Sady, S.P., and Thompson, P.D. (1985). Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity. Med. Sci. Sports Exerc. 17: 462-465.
36. Kennedy, M.C., Corrigan, A.B., and Pilbeam, S.T.H.H. (1993). Myocardial infarction and cerebral haemorrhage in a young bodybuilder taking anabolic steroids. Aust. N.Z.J. Med. 23: 713.
37. Kibble, M.W., and Ross, M.B. (1987). Adverse effects of anabolic steroids in athletes. Clin. Pharm. 6:686-692.
38. Kramhoft, M., and Solgaard, S. (1986). Spontaneous rupture of the extensor pollicis longus tendon after anabolic steroids. J. Hand Surg. (Br.) 11: 87.
39. LaBree, M. (1991). A review of anabolic steroids: Uses and effects. J. Sports Med. Phys. Fit. 31: 618-626.
40. Lamb, D.R., and Williams, M.H. (1991). Ergogenics. Ann Arbor, MI: Brown.
41. Laseter, J.T., and Russell, J.A. (1991). Anabolic steroid-induced tendon pathology: a review of the literature. Med. Sci. Sports Exerc. 23: 1-3.
42. Lemcke, B., Zentgraf, J., Behre, H.M., Kliesch, S., Bramswig, J.H., and Nieschlag, E. (1996). Long-term effects on testicular function of high-dose testosterone treatment for excessively tall stature. J. Clin. Endo. Metab. 81: 296-301.
43. Limbird, T.J. (1985). Anabolic steroids in the training and treatment of athletes. Compr. Then 11:25-30.
44. Lindstrom, M., Nilsson, A.L., Katzman, PL., Janzon, L., and Dymling, J.F. (1990). Use of anabolic-androgenic steroids among bodybuilders-frequency and attitudes. J. Int. Med. 227: 407-411.
45. Liow, R.Y.L., and Tavares, S. (1995). Bilateral rupture of the quadriceps tendon associated with anabolic steroids. Br. J. Sports Med. 29: 77-79.
46. Lukas, S.E. (1993). Current perspectives on anabolic-androgenic steroid abuse. Trends Pharm. Sci. 14:61-68.
47. Luke, J.L., Farb, A., Virmani, R., and Barry Sample, R.H. (1990). Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: Pathological and toxicological findings. J. Foren. Sci. 35: 1441-1447.
48. McKillop, G. (1987). Drug abuse in bodybuilders in the West of Scotland. Scot. Med. J. 32: 39-41.
49. McNutt, R.A., Ferenchick, G.S., Kirlin, P.C., and Hamlin, N.J. (1988). Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. A. J. Cardiol. 62: 164.
50. Michna, H. (1987). Tendon injuries induced by exercise and anabolic steroids in experimental mice. Int. Orthop. 11: 157-162.
51. Millar, A.P. (1994). Licit steroid use-hope for the future. Br. J. Sports Med. 28: 79-83.
52. Montine, T.J., and Gaede, J.T. (1992). Massive pulmonary embolus and anabolic steroid abuse. JAMA 267: 2328-2329.
53. O'Connor, J.S., Baldini, F.D., Skinner, J.S., and Einstein, M. (1990). Blood chemistry of current and previous anabolic steroid users. Military Med. 155: 72-75.
54. Olweus, D., Mattsson, A., and Schalling, D. (1980). Testosterone, aggression physical, and personality dimensions in normal adolescent males. Psychosoin. Med. 42: 253-267.
55. Overly, W.L., Dankoff, J.A., Wang, B.K., and Singh, U.D. (1984). Androgens and hepatocellular carcinoma in the athlete. Ann. Intern. Med. 100: 158.
56. Payne, A.H. (1975). Anabolic steroids in athletics. Br. J. Sports Med. 16: 169.
57. Phillips, W.P. (1991). Anabolic Reference Guide. Golden, CO: Mile High.
58. Pope, H.G., and Katz, D. (1988). Affective and psychotic symptoms associated with anabolic steroid use. Am. J. Psych. 145: 487-490.
59. Pope, H.G., Katz, D.L., and Champoux, R. (1988). Anabolic-androgenic steroid use among 1,010 college men. Phys. Sports Med. 16: 75-82.
60. Recant, L., and Lacy, P.(Eds.) (1965). Fanconi's anemia and hepatic cirrhosis: Clinicopathological Conference. Am. J. Med. 39: 464-475.
61. Roberts, J.T., and Essenhigh, D.M. (1986). Adenocarcinoma of prostate in 40-year-old bodybuilder. Lancet 2: 742.
62. Robinson, R.J., and White, S. (1993). Misuse of anabolic drugs. Br. Med. J. 306: 61.
63. Schurmeyer, T., Belkien, L., Knuth, U.A., and Nieschlag, E. (1984). Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. Lancet 1: 417.
64. Silvester, L.J. (1995). Self-perceptions of the acute and long-range effects of anabolic-an- drogenic steroids. J. Strength Cond. 9: 95-98.
65. Soe, K.L., Soe, M., and Gluud, C. (1992). Liver pathology associated with the use of anabolic-androgenic steroids. Liver 12:73-79.
66. Stannard, J.P., and Bucknell, A.L. (1993). Rupture of the triceps tendon associated with steroid injections. Am. J. Sports Med. 21: 482-485.
67. Strauss, R.H., Liggett, M.T., and Lanese, R.R. (1985). Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA 253: 2871-2873.
68. Strauss, R.H., Wright, J.E., and Finerman, G. A.M. (1983). Side effects of anabolic steroids in weight-trained men. Phys. Sports Med. 11: 87-95.
69. Thompson, P.D., Sadaniantz, A., Cullinane, E.M., Bodziony, K.S., Catlin, D.H., TorekBoth, G., and Douglas, P.S. (1992). Left ventricular function is not impaired in weight-lifters who use anabolic steroids. J. Am. College Cardiol. 19:278-282.
70. Uzych, L. (1992). Anabolic-androgenic steroids and psychiatric-related effects: a review. Can. J. Psych. 37: 23-28.
71. Visuri, T., and Lindolm, H. (1994). Bilateral distal biceps tendon avulsions with use of anabolic steroids. Med. Sci. Sports Exerc. 26: 941-944.
72. Wade, N. (1972). Anabolic steroids: Doctors denounce them, but athletes aren't listening. Science. 176:1399-1403.
73. Wang, C., Alexander, G., Berman, N., Salahian, B., Davidson, T., and McDonald, V. (1995). Effect of testosterone replacement therapy on mood changes in hypogonadal men. Endo. Soc. June: P2-122.
74. Webb, O.L., Laskarzewski, P.M., and Glueck, C.J. (1984). Severe depression of high density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism 33: 971-975.
75. Wilson, J.D. (1988). Androgen abuse by athletes. Endo. Rev. 9: 181-199.
76. Wilson, J.D., and Griffin, J.E. (1980). The use and misuse of androgens. Metabolism 29: 1278-1295.
77. Windsor, R.E., and Dumitru, D. (1988). Anabolic steroid use by athletes. Postgrad. Med. 84: 37-49.
78. Windsor, R., and Dumitru, D. (1989). Prevalence of anabolic steroid use by male adolescents. Med. Sci. Sports Exerc. 21: 494-497.
79. Winwood, P.J., Robertson, D.A.F., and Wright, R. (1990). Bleeding oesophageal varices associated with anabolic steroid use in an athlete. Postgrad. Med. J. 66: 864-865.
80. World Health Organization Task Force on Methods For The Regulation of Male Fertility. (1990). Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336: 955-959.
81. Yates, W.R., Perry, P., and Murray, S. (1992). Aggression and hostility in anabolic steroid users. Biol. Psych. 31: 1232-1234.
82. Yesalis, C.E., Kennedy, N.J., Kopstein, A.N., and Bahrke, M.S. (1993). Anabolic-androgenic steroid use in the United States. JAMA 270: 1217-1221.